Synmosa Biopharma Corporation (TPEX:4114)
32.05
-0.30 (-0.93%)
Mar 2, 2026, 1:30 PM CST
5.38% (1Y)
| Market Cap | 16.22B |
| Revenue (ttm) | 6.11B |
| Net Income (ttm) | 769.95M |
| Shares Out | 501.47M |
| EPS (ttm) | 1.58 |
| PE Ratio | 20.48 |
| Forward PE | n/a |
| Dividend | 0.55 (1.69%) |
| Ex-Dividend Date | Jul 11, 2025 |
| Volume | 572,276 |
| Average Volume | 1,021,771 |
| Open | 32.15 |
| Previous Close | 32.35 |
| Day's Range | 31.75 - 32.25 |
| 52-Week Range | 26.28 - 39.80 |
| Beta | -0.04 |
| RSI | 47.24 |
| Earnings Date | Mar 30, 2026 |